Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Finasteride niosomes were developed and found to be effective in treating hair loss, with better results than commercial minoxidil, and could be a promising topical treatment for hair loss.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Anabolic-androgenic steroids can harm women's health and their offspring.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Kigelia africana fruit extract can prevent and reverse prostate enlargement in rats.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Zinc and copper levels may affect erectile dysfunction by influencing hormone levels.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Melatonin affects skin and hair color and protects skin cells, with potential benefits for hair growth and skin health.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Aesthetic care should align physical changes with mental well-being using a comprehensive, multidisciplinary approach.